Cargando…
LRRC15 is an inhibitory receptor blocking SARS-CoV-2 spike-mediated entry in trans
SARS-CoV-2 infection is mediated by the entry receptor ACE2. Although attachment factors and co-receptors facilitating entry are extensively studied, cellular entry factors inhibiting viral entry are largely unknown. Using a surfaceome CRISPR activation screen, we identified human LRRC15 as an inhib...
Autores principales: | Song, Jaewon, Chow, Ryan D., Pena-Hernandez, Mario, Zhang, Li, Loeb, Skylar A., So, Eui-Young, Liang, Olin D., Wilen, Craig B., Lee, Sanghyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629192/ https://www.ncbi.nlm.nih.gov/pubmed/34845449 http://dx.doi.org/10.1101/2021.11.23.469714 |
Ejemplares similares
-
LRRC15 inhibits SARS-CoV-2 cellular entry in trans
por: Song, Jaewon, et al.
Publicado: (2022) -
LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein
por: Shilts, Jarrod, et al.
Publicado: (2023) -
Exploiting LRRC15 as a Novel Therapeutic Target in Cancer
por: Ray, Upasana, et al.
Publicado: (2022) -
Targeting LRRC15 Inhibits Metastatic Dissemination of Ovarian Cancer
por: Ray, Upasana, et al.
Publicado: (2022) -
LRRC15 Targeting in Soft-Tissue Sarcomas: Biological and Clinical Implications
por: Ben-Ami, Eytan, et al.
Publicado: (2020)